Medicines

  1. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
    €1,137.29
  2. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €23.84
  3. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,520.00
  4. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €735.00
  5. Kevzara (sarilumab)
    Kevzara (sarilumab)
    by Sanofi - Aventis Groupe
    for Rheumatoid Arthritis
    €1,317.75
  6. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €1,692.00
  7. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €4,389.00
  8. Lartruvo (olaratumab)
    Lartruvo (olaratumab)
    by Eli Lilly Nederland B.V.
    for Soft Tissue Sarcoma
    €660.00
View as Grid List

Items 28-36 of 62

per page
Set Descending Direction